Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Renal cell carcinoma
Age: Adult
Condition: As an adjunct to cytotoxic chemotherapy
Dose: Subcutaneous – 3 million units
Frequency: 3 times weekly
Duration: 1 week
Note: Escalating dose
Indication: Renal cell carcinoma
Age: Adult
Condition: As an adjunct to cytotoxic chemotherapy
Dose: Subcutaneous – 9 million units
Frequency: 3 times weekly
Duration: 1 week
Note: Escalating dose

Child Dose

Clinical InformationAdministration Information
Indication: Chronic hepatitis C
Age: 5 years of age and older
Dose: Subcutaneous Injection – 180 mcg/1.73 m2 x body surface area
Frequency: Once weekly
Note: Subcutaneous
Indication: Chronic hepatitis B
Age: 3 years of age and older
Dose: Subcutaneous Injection – 180 mcg/1.73 m2 x body surface area
Frequency: Once weekly
Note: Subcutaneous
Administration
  • Given by injection
  • Medical supervision needed
Side Effect

Drug Interaction

Drug NameRisk Factors
Theophylline
Reduces clearance
Zidovudine, Ganciclovir, Valganciclovir, Dapsone, Doxorubicin, Vincristine, Vinblastine
Enhanced myelosuppression

Disease Interaction

Disease NameRisk Factors
Autoimmune Hepatitis
Can worsen liver inflammation
Hepatic Decompensation
Can worsen liver function

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.